State Street’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.74M | Sell |
2,381,311
-345,443
| -13% | -$833K | ﹤0.01% | 2885 |
|
|
2025
Q1 | $6.03M | Sell |
2,726,754
-54,043
| -2% | -$119K | ﹤0.01% | 2805 |
|
|
2024
Q4 | $15.2M | Buy |
2,780,797
+30,024
| +1% | +$164K | ﹤0.01% | 2377 |
|
|
2024
Q3 | $22.9M | Sell |
2,750,773
-16,338
| -0.6% | -$136K | ﹤0.01% | 2129 |
|
|
2024
Q2 | $19.8M | Buy |
2,767,111
+730,837
| +36% | +$5.23M | ﹤0.01% | 2177 |
|
|
2024
Q1 | $17.7M | Buy |
2,036,274
+20,906
| +1% | +$181K | ﹤0.01% | 2248 |
|
|
2023
Q4 | $13.2M | Buy |
2,015,368
+207,869
| +12% | +$1.36M | ﹤0.01% | 2437 |
|
|
2023
Q3 | $18.1M | Sell |
1,807,499
-26,994
| -1% | -$270K | ﹤0.01% | 2227 |
|
|
2023
Q2 | $22.8M | Sell |
1,834,493
-5,975
| -0.3% | -$74.3K | ﹤0.01% | 2168 |
|
|
2023
Q1 | $25.8M | Buy |
1,840,468
+32,279
| +2% | +$452K | ﹤0.01% | 2052 |
|
|
2022
Q4 | $25.9M | Buy |
1,808,189
+53,213
| +3% | +$761K | ﹤0.01% | 2050 |
|
|
2022
Q3 | $44.8M | Buy |
1,754,976
+6,088
| +0.3% | +$155K | ﹤0.01% | 1663 |
|
|
2022
Q2 | $49.7M | Sell |
1,748,888
-61,429
| -3% | -$1.75M | ﹤0.01% | 1638 |
|
|
2022
Q1 | $63.9M | Buy |
1,810,317
+201,284
| +13% | +$7.1M | ﹤0.01% | 1604 |
|
|
2021
Q4 | $67.4M | Buy |
1,609,033
+222,158
| +16% | +$9.31M | ﹤0.01% | 1599 |
|
|
2021
Q3 | $68.1M | Buy |
1,386,875
+166,491
| +14% | +$8.17M | ﹤0.01% | 1578 |
|
|
2021
Q2 | $50.9M | Buy |
1,220,384
+571,855
| +88% | +$23.9M | ﹤0.01% | 1834 |
|
|
2021
Q1 | $23.1M | Buy |
+648,529
| New | +$23.1M | ﹤0.01% | 2277 |
|